Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eira Valeria Barrón"'
Publikováno v:
Diagnostic Pathology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background COVID-19 was initially described as a severe acute respiratory disease that could drive to pneumonia, compromising the life of the patients in the worst scenario. However, even though in most of the cases the respiratory symptoms
Externí odkaz:
https://doaj.org/article/9ed08f85fe5041b1b0d0e2f78966a9bd
Autor:
Ireri Thirión-Romero, Rosario Fernández-Plata, Midori Pérez-Kawabe, Patricia A. Meza-Meneses, Carlos Alberto Castro-Fuentes, Norma E. Rivera-Martínez, Eira Valeria Barrón-Palma, Ana Laura Sánchez-Sandoval, Patricia Cornejo-Juárez, Jesús Sepúlveda-Delgado, Darwin Stalin Torres-Erazo, José Rogelio Pérez-Padilla
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1779 (2023)
Background: Phase III clinical trials have documented the efficacy of the SARS-CoV-2 vaccines in preventing symptomatic COVID-19. Nonetheless, it is imperative to continue analyzing the clinical response to different vaccines in real-life studies. Ou
Externí odkaz:
https://doaj.org/article/3b330242b49444eca94834c5b9c0c38d
Autor:
Edna Marquez, Eira Valeria Barrón-Palma, Katya Rodríguez, Jesus Savage, Ana Laura Sanchez-Sandoval
Publikováno v:
Diagnostics, Vol 13, Iss 21, p 3352 (2023)
Influenza has been a stationary disease in Mexico since 2009, and this causes a high cost for the national public health system, including its detection using RT-qPCR tests, treatments, and absenteeism in the workplace. Despite influenza’s relevanc
Externí odkaz:
https://doaj.org/article/2baeb0c718a04415903848aa61c807cc
Autor:
Nallely Bueno-Hernández, José Damian Carrillo-Ruíz, Lucía A. Méndez-García, Salma A. Rizo-Téllez, Rebeca Viurcos-Sanabria, Alisson Santoyo-Chávez, René Márquez-Franco, Alejandro Aguado-García, Neyla Baltazar-López, Yoshio Tomita-Cruz, Eira Valeria Barrón, Ana Laura Sánchez, Edna Márquez, Ruben Fossion, Ana Leonor Rivera, Luis Ruelas, Octavio A. Lecona, Gustavo Martínez-Mekler, Markus Müller, América G. Arroyo-Valerio, Galileo Escobedo
Publikováno v:
Healthcare, Vol 10, Iss 5, p 896 (2022)
Health care workers (HCW) are at high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The incidence of SARS-CoV-2 infection in HCW has been examined in cross-sectional studies by quantitative polymerase chain reaction
Externí odkaz:
https://doaj.org/article/f1a438ea8bd1499fb6b0f0db68dcf877
Autor:
Eira Valeria Barrón, Edgar Roman-Bassaure, Ana Laura Sánchez-Sandoval, Ana María Espinosa, Mariano Guardado-Estrada, Ingrid Medina, Eligia Juárez, Ana Alfaro, Miriam Bermúdez, Rubén Zamora, Carlos García-Ruiz, Juan Carlos Gomora, Susana Kofman, E Martha Pérez-Armendariz, Jaime Berumen
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137397 (2015)
The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 co
Externí odkaz:
https://doaj.org/article/5bba3a8512be4099bd31618908bcd503
Autor:
Jahir Rodríguez-Morales, Sebastián Guartazaca-Guerrero, Salma A. Rizo-Téllez, Rebeca Viurcos-Sanabria, Eira Valeria Barrón, Aldo F. Hernández-Valencia, Porfirio Nava, Galileo Escobedo, José Damián Carrillo-Ruiz, Lucía A. Méndez-García
Publikováno v:
Experimental Neurobiology. 31:270-276
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ba0e985193b3a96a4f3de8e6d277a6b
https://doi.org/10.5607/en21049
https://doi.org/10.5607/en21049
Autor:
Susana Kofman, Rubén Zamora, Jaime Berumen, Ana Laura Sanchez-Sandoval, E. Martha Pérez-Armendariz, Eligia Juárez, Carlos García-Ruiz, Juan Carlos Gomora, Ana Alfaro, Edgar Román-Bassaure, Ana María Espinosa, Eira Valeria Barrón, Ingrid Medina, Mariano Guardado-Estrada, Miriam Bermúdez
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137397 (2015)
PLoS ONE
PLoS ONE
The cyclin-dependent kinase inhibitor 3 (CDKN3) gene, involved in mitosis, is upregulated in cervical cancer (CC). We investigated CDKN3 mRNA as a survival biomarker and potential therapeutic target for CC. CDKN3 mRNA was measured in 134 CC and 25 co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28286a4c5f6dd819ca31f3f012708883
https://doi.org/10.1371/journal.pone.0137397
https://doi.org/10.1371/journal.pone.0137397